The COVID-19 pandemic continues to rage over the world, with certain nations, such as India, seeing unprecedented levels of infection, wreaking havoc on population health as well as social and economic well-being. In other parts of the world, significant progress has been made in controlling the disease, most notably in Israel, where about 60% of the population has received two vaccinations. The creation and production of vaccinations is a stunning display of medical and technological progress. Vaccines have a unique market in a number of ways that set it distinct from other sectors.
Title : Managing bacterial eradication in disease and survival for life support systems on earth and space
AC Matin, Stanford University, United States
Title : Buffers and homeostasis: A key to maintaining health
Jawad Alzeer, University of Zurich, Switzerland
Title : An update of Lyme disease with particular reference to low endemic areas in Canada
Muhammad Morshed, University of British Columbia, Canada
Title : Antimicrobial activity of Zinc oxide nano particles against multi drug resistant Escherichia coli clinical isolates
Noha Tharwat Abou El Khier, Mansoura University, Egypt
Title : Microbial adhesion capacity on orthopedic implants
Bohinc Klemen, Faculty of Health Sciences, University of Ljubljana, Slovenia
Title : Evaluation of the anti-diabetic potential of probiotic lactobacillus fermentum (pri 29) isolated from cameroonian fermented cow milk in alloxan induced diabetes type-1 mice model
Tanyi Pride Bobga, University of Buea, Cameroon